See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $421B | 5.0x | 18.1x | |
| $393B | 6.8x | 15.1x | |
| $225B | 4.6x | 19.1x | |
| $180B | 2.7x | 12.6x | |
| $82.0B | 4.1x | 16.5x | |
| $63.9B | 1.2x | 5.8x | |
| $63.8B | 8.6x | 37.5x | |
| $60.8B | 4.0x | 16.0x | |
| $55.8B | 2.9x | 10.3x | |
| $54.4B | 2.7x | 13.6x | |
| $53.1B | 3.4x | 14.5x | |
| $50.4B | 5.6x | 23.0x | |
| $32.2B | 6.8x | 29.3x | |
| $32.0B | 1.3x | 7.4x | |
| $31.5B | 2.2x | 16.0x | |
| $27.5B | 2.5x | 14.1x | |
| $25.3B | 4.1x | 18.1x | |
| $23.0B | 1.5x | 8.4x | |
| $22.0B | 2.2x | 6.4x | |
| $20.8B | 1.8x | 12.5x | |
| $20.3B | 1.8x | 11.4x | |
| $15.0B | 8.8x | 41.6x | |
| $12.6B | 8.5x | 33.8x | |
| $12.1B | 2.1x | 15.4x | |
| $11.5B | 2.1x | 10.4x | |
| $11.3B | 1.6x | 8.8x | |
| $10.8B | 8.3x | 42.1x | |
| $9.8B | 6.6x | 35.5x | |
| $8.3B | 1.4x | 7.7x | |
| $8.1B | 9.4x | 21.7x | |
| $7.9B | 1.2x | 11.2x | |
| $7.8B | 10.9x | 33.6x | |
| $6.9B | 1.6x | 9.3x | |
| $6.5B | 4.8x | 21.6x | |
| $6.2B | 13.9x | 44.3x | |
| $6.1B | 2.3x | 10.6x | |
| $5.7B | 1.9x | 13.9x | |
| $5.3B | 10.4x | 43.9x | |
| $5.1B | 4.5x | 13.6x | |
| $4.8B | 1.4x | 8.1x | |
| $4.4B | 2.8x | 14.9x | |
| $4.4B | 2.9x | 14.4x | |
| $4.1B | 1.9x | 12.9x | |
| $3.9B | 5.5x | 25.2x | |
| $3.5B | 11.0x | 44.9x | |
| $3.3B | 3.2x | 22.1x | |
| $3.3B | 0.6x | 6.0x | |
| $3.1B | 4.8x | 23.4x | |
| $3.1B | 3.1x | 13.8x | |
| $3.0B | 0.6x | 5.8x | |
| $3.0B | 1.0x | 5.8x | |
| $3.0B | 1.4x | 8.2x | |
| $2.9B | 6.5x | 23.9x | |
| $2.6B | 1.2x | 7.6x | |
| $2.6B | 1.2x | 10.2x | |
| $2.5B | 1.0x | 5.1x | |
| $2.5B | 0.9x | 7.3x | |
| $2.3B | 0.8x | 4.9x | |
| $2.2B | 2.7x | 17.9x | |
| $2.2B | 2.0x | -73.7x | |
| $2.1B | 1.1x | 9.2x | |
| $2.1B | 1.2x | 10.7x | |
| $2.1B | 3.4x | 20.5x | |
| $2.1B | 3.4x | 16.5x | |
| $1.9B | 5.0x | 14.0x | |
| $1.6B | 1.3x | 9.9x | |
| $1.6B | 0.7x | 7.8x | |
| $1.6B | 0.8x | 5.6x | |
| $1.4B | 2.5x | 10.2x | |
| $1.4B | 0.7x | 5.9x | |
| $1.4B | 5.0x | 11.3x | |
| $1.4B | 1.2x | 9.4x | |
| $1.2B | 4.7x | 115.0x | |
| $1.1B | 8.2x | 30.8x | |
| $1.1B | 1.5x | 6.2x | |
| $1.0B | 1.5x | 10.8x | |
| $947M | 2.2x | 8.4x | |
| $723M | n/a | n/a | |
| $694M | n/a | n/a | |
| $665M | 2.2x | -170.1x | |
| $654M | 0.9x | 6.3x | |
| $626M | 0.2x | 1.5x | |
| $564M | 0.8x | 4.2x | |
| $546M | 1.2x | 5.8x | |
| $520M | 3.4x | 13.9x | |
| $513M | 2.2x | 23.6x | |
| $502M | 0.3x | n/a | |
| $496M | 1.3x | 18.3x | |
| $493M | 1.7x | 11.5x | |
| $493M | 0.4x | 4.8x | |
| $491M | 2.4x | -34.8x | |
| $491M | n/a | n/a | |
| $447M | 1.1x | 7.5x | |
| $398M | 1.3x | 25.8x | |
| $379M | n/a | n/a | |
| $345M | n/a | n/a | |
| $330M | n/a | n/a | |
| $309M | 1.2x | n/a | |
| $298M | 0.8x | 9.1x | |
| $272M | n/a | n/a | |
| $254M | 5.3x | 19.5x | |
| $226M | 1.1x | 7.1x | |
| $216M | 0.4x | 10.2x | |
| $185M | 0.9x | 9.8x | |
| $178M | n/a | n/a | |
| $178M | 0.6x | 7.2x | |
| $148M | 2.3x | 10.4x | |
| $139M | 2.4x | 7.7x | |
| $125M | n/a | n/a | |
| $100M | n/a | n/a | |
| $93.0M | 0.4x | 4.5x | |
| $45.1M | 1.8x | 7.4x | |
| $42.1M | n/a | n/a | |
| $36.6M | n/a | n/a | |
| $34.0M | 0.7x | 5.3x | |
| $33.8M | n/a | n/a | |
| $23.1M | 1.7x | n/a | |
| $21.6M | 0.9x | -226.7x | |
| $17.4M | n/a | n/a | |
| $16.7M | n/a | n/a | |
| $15.8M | n/a | n/a | |
| $10.1M | n/a | n/a | |
| $5.6M | n/a | n/a | |
| $3.2M | 0.0x | 0.1x | |
| $0.7M | n/a | n/a | |
| $0.6M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty